Table 2 Dermal histopathological characteristics before and after treatment
Dermis | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intensity | Distribution | Cellular type | ||||||||||
Intense | Moderate | Light | Focal | Diffuse | Neutrophil | Eosinophil | Mono nuclear cells | |||||
≤ 10% | Absence | ≤ 10% | Absence | ≥ 10% | ≤ 10% | Absence | ||||||
APG + Glucantime | ||||||||||||
Before; n (%) | 6 (40.0) | 8 (53.3) | 1 (06.7) | 9 (60.0) | 6 (40.0) | 6 (40.0) | 9 (60.0) | 3 (20.0) | 12 (80.0) | 11 (73.3) | 4 (26.7) | 0 |
After; n (%) | 0 | 6(40.0) | 9 (60.0) | 11 (73.3) | 4 (26.7) | 2 (13.3) | 13 (86.7) | 1 (06.7) | 14 (93.3) | 0 | 15 (100) | 0 |
Glucantime | ||||||||||||
Before; n (%) | 5 (33.3) | 10 (66.6) | 0 | 7 (46.6) | 8 (53.3) | 7 (46.6) | 8 (53.3) | 2 (13.3) | 13 (86.6) | 10 (66.6) | 5 (33.3) | 0 |
After; n (%) | 0 | 9(60.0) | 6 (40.0) | 9 (60.0) | 6 (40.0) | 4 (26.7) | 11 (73.3) | 0 | 15 (100) | 6 (40.0) | 9 (60.0) | 0 |